PBEvsSPYG
Invesco Dynamic Biotechnology & Genome ETF against SPDR Portfolio S&P 500 Growth ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| PBE | SPYG | |
|---|---|---|
| Expense ratio | 0.58% | 0.040% |
| Assets | $414M | $56.7B |
| Net flow, 1 month | +$3M | +$1.4B |
| Net flow, 1 year | +$114M | +$4.9B |
| Return, YTD | +18.1% | +17.8% |
| Return, 1 year | — | — |
| Avg daily volume | 13K | 2.1M |
| Holdings | 31 | 228 |
| Listed | Jun 23, 2005 | Sep 25, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS